Cancer Letters · 2004 · 114 citations · 19 references
Life SciencesOncologyPharmacologyApoptosisCancer PharmacologyCell DivisionApoptosis In CancerCell Cycle SignalingCell-cycle ArrestCell-cycle CheckpointsLung CancerMalignant NeoplasmsCell Cycle InhibitionCell Cycle InhibitorsNon-small Cell Lung Cancer Therapy
19
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Lawrence A. Donehower, Michele Harvey, Betty L. Slagle et al. · Nature · 1992 · 4.7K citations
Lethal effect of the anti-Fas antibody in mice
Jun Ogasawara, Rie Watanabe‐Fukunaga, Masashi Adachi et al. · Nature · 1993 · 1.9K citations
Life Sciences, Immunology, Pathology +14
Metalloproteinase-mediated release of human Fas ligand.
Nobuhiko Kayagaki, Tomohiko Ebata, Hiroshi Ohmoto et al. · The Journal of Experimental Medicine · 1995 · 831 citations · Full text
Life Sciences, Immunology, Pathology +15
Apoptosis, p53, and tumor cell sensitivity to anticancer agents.
Jeremy Brown, Bradly G. Wouters · PubMed · 1999 · 702 citations
Medicine, Cancer Biology, Oncology +17